Viatris Inc (VTRS) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Total Cash From Operating Activities Chart for Viatris Inc

Viatris Inc (VTRS) operating cash flow for FY2025 was USD 2.3B, a 0.6% change from FY2024. Viatris Inc's operating cash flow grew from USD 51.2M in 1985 to USD 2.3B in 2025 (4423.2% over 40 years). Operating cash flow compound annual growth rate: 5-year CAGR of 13.5%, 10-year CAGR of 1.4%, 20-year CAGR of 9.0%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Cash From Operating Activities (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$18.64B
Implied Share Price
$16.23
Enterprise Value
$30.77B
Revenue (TTM)
$14.74B
EBITDA
$4.29B
Profit Margin
-2.79%
Trailing P/E
—
Forward P/E
6.49
Price/Book (MRQ)
1.31
Price/Sales (TTM)
1.26
EV/EBITDA
11.74
EV/Revenue
2.09
Dividend Yield
2.99%
Book Value
$12.59
Free Cash Flow (FY2025)
$1.94B
Free Cash Flow Yield
10.39%

Snapshot as of 16th August 2026 — not point-in-time controlled, may lag the live market by a few days.